LUNG (Pulmonx Corp.) Prakiraan pendapatan perusahaan

Tandha merek pulmonx.com (LUNG)

Pulmonx Corporation (LUNG) margin scalability is increasing due to lower manufacturing costs. The company's projected sales volume on GURU.Markets is available for analysis, where the 0.09 mark indicates the current status. Service offerings and software worldwide provide stable income, while FDA approvals create a powerful defensive barrier against new entrants in the emphysema treatment segment.

LUNG - Volume dodolan sing dikarepake perusahaan Pulmonx Corporation ing rentang 04.07.2022 - 18.11.2026

Rincian analitis lan laporan data perusahaan Pulmonx Corporation (LUNG)

- rega saiki lan proyeksi nilai saham:
Analisis fundamental perusahaan:Pulmonx Corp
Produk merek Pulmonx Corp.

The innovative potential of Pulmonx Corporation (LUNG) relies on the synergy between medical professionals and engineers developing high-tech therapy systems. The metric algorithm aggregates expected cash flows from the sale of these products, transforming sales forecasts into a quantitative equivalent. This indicator measures the future market value of the business through the lens of expected revenue, allowing investors to objectively assess the degree of the asset's undervaluation. Analyzing the organization's sales forecast helps avoid emotional decision-making when determining fair capitalization.

Analisis perusahaan pesaing

Volume dodolan mangsa ngarep perusahaan DXCM (Dexcom)|Volume dodolan mangsa ngarep perusahaan Penumbra PEN|Prakiraan pendapatan perusahaan Novanta Photonics NOVT|Haemonetics Corp. (HAE) - Volume dodolan sing dikarepake perusahaan|Inspire Medical - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan PROCEPT BioRobotics|CNMD: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PLSE|INMD (InMode MD) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Picard Medical Inc. (PMI)|Prakiraan volume dodolan SRDX|Volume dodolan mangsa ngarep perusahaan Senseonics Holdings SENS|Prakiraan volume dodolan NPCE (neuropace.com)|Prakiraan volume dodolan Tactile Systems Technology TCMD|SNWV - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Outset Medical Corp|ELMD (Electromed Inc) - Volume dodolan mangsa ngarep perusahaan|LENSAR, Inc. - Pendapatan mangsa ngarep perusahaan|RCEL (AVITA Medical Inc) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan profoundmedical.com PROF|Prakiraan pendapatan perusahaan Baird Medical (BDMD)|EDAP Medical (EDAP) - Prakiraan dodolan perusahaan|Apyx Medical Corp - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan IceCure Medical, Ltd. ICCM|TELA Bio Inc. - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan CytoSorbents Corporation CTSO|Sensus Healthcare (SRTS) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan ZYXI (Zynex Corp)|Prakiraan pendapatan perusahaan electrocore.com|Volume dodolan mangsa ngarep perusahaan Vicarious Surgical Inc. (RBOT)|Prakiraan volume dodolan IINN|SeaStar Medical Holding Corp - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan iridex.com IRIX|INBS: Prakiraan pendapatan perusahaan|XAIR: Volume dodolan mangsa ngarep perusahaan|profusa.com - Prakiraan volume pendapatan perusahaan|STRATA Skin Sciences (SSKN) - Prakiraan pendapatan perusahaan|Prakiraan dodolan perusahaan glucotrack.com GCTK|NAOV (nanovibronix.com) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Venus Concept Corporation VERO|Volume dodolan mangsa ngarep perusahaan NUWE (nuwellis.com)|Prakiraan volume pendapatan perusahaan AEMD|Prakiraan pendapatan perusahaan asensus.com ASXC|AVGR: Prakiraan pendapatan perusahaan|BioSig Technologies, Inc - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan CUTR (Cutera, Inc)|KNW: Prakiraan volume dodolan|inarimedical.com - Pendapatan mangsa ngarep perusahaan|NVRO (Nevro Corp) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan ReShape Lifesciences Inc. RSLS|Prakiraan volume dodolan SILK